# Cardinal Health, Inc. (CAH) FY2025 Q3 P&L / Income Statement

- Company: Cardinal Health, Inc. (CAH)
- Period: 2025-01-01 to 2025-03-31
- Filing: Q3 FY2025 10-Q, filed 2025-05-01, accession number 0000721371-25-000038
- Page: https://plicit.ai/financials/cah/fy2025-q3-income-statement
- Chart image: https://plicit.ai/charts/cah-fy2025-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 54,878,000,000 US dollars
- **Cost of products sold**: 52,755,000,000 US dollars
- **Gross margin**: 2,123,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 1,393,000,000 US dollars
- **Operating earnings**: 730,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 65,000,000 US dollars
- **Earnings/(loss) before income taxes**: 665,000,000 US dollars
- **Provision for income taxes**: 157,000,000 US dollars
- **Net earnings/(loss)**: 508,000,000 US dollars
- **Pharmaceutical and Specialty Solutions**: 50,433,000,000 US dollars
- **Global Medical Products and Distribution**: 3,160,000,000 US dollars
- **Other Segments**: 1,304,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 1,315,000,000 US dollars
- **Restructuring and employee severance**: 28,000,000 US dollars
- **Amortization and other acquisition-related costs**: 152,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 20,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: negative 17,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 105,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 54,897,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Corporate**: negative 19,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmaceutical and Specialty Solutions costs (calculated)**: 49,771,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Global Medical Products and Distribution costs (calculated)**: 3,121,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Other Segments costs (calculated)**: 1,170,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 86,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $506.00 M; to noncontrolling interests: $2.00 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/cah/fy2025-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/cah-fy2025-q3-revenue-by-geography-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 54,878,000,000 US dollars
- **Cost of products sold**: 52,755,000,000 US dollars
- **Gross margin**: 2,123,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 1,393,000,000 US dollars
- **Operating earnings**: 730,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 65,000,000 US dollars
- **Earnings/(loss) before income taxes**: 665,000,000 US dollars
- **Provision for income taxes**: 157,000,000 US dollars
- **Net earnings/(loss)**: 508,000,000 US dollars
- **UNITED STATES**: 54,498,000,000 US dollars
- **Non-US**: 399,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 1,315,000,000 US dollars
- **Restructuring and employee severance**: 28,000,000 US dollars
- **Amortization and other acquisition-related costs**: 152,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 20,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: negative 17,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 105,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 54,897,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 19,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $506.00 M; to noncontrolling interests: $2.00 M.